v3.26.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Net income $ 129,776 $ 141,446
Gain on real estate transactions (1,209) (26,163)
Deferred income tax expense (benefit) 369 (623)
Financing Receivable, Credit Loss, Expense (Reversal) (5,459) 345
Equity in loss from joint ventures (3,616) (4,328)
Proceeds from Equity Method Investment, Distribution 7 11
Depreciation and amortization 93,587 83,169
Amortization of deferred financing costs 5,371 4,308
Amortization of above/below market leases and tenant allowances, net (156) (162)
Share-based Payment Arrangement, Noncash Expense 8,395 7,779
share based compensation included in severance expense 1,041 0
Increase (Decrease) in Operating Lease Assets and Liabilities, Net (1,307) (552)
Mortgage notes accrued interest receivable (1,268) (421)
Accounts receivable (13,653) (12,481)
Other assets (2,943) (4,877)
Accounts payable and accrued liabilities (435) (6,401)
Increase (Decrease) in Deferred Revenue (9,196) (3,016)
Net cash provided by operating activities 206,536 186,690
Investing activities:    
Payments to Acquire Productive Assets 458,359 19,541
Proceeds from Sale of Productive Assets 690 106,436
Investment in mortgage notes receivable (14,695) (9,776)
Proceeds from Sale and Collection of Mortgage Notes Receivable 11,065 9,458
Proceeds from promissory note receivable paydown 227 279
Additions to properties under development (19,207) (57,033)
Net cash (used) provided by investing activities (480,279) 29,823
Financing activities:    
Proceeds from long-term debt facilities 435,000 414,000
Repayments of Long-Term Debt (75,000) (484,000)
Deferred financing fees paid (413) (446)
Net proceeds from issuance of common shares 502 464
Purchase of common shares for treasury (13,144) (9,833)
Dividends paid to shareholders (150,587) (144,091)
Net cash provided (used) by financing activities 196,358 (223,906)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (678) 414
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (78,063) (6,979)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20,585 28,720
Cash and Cash Equivalent 16,197 12,955
Restricted Cash and Cash Equivalent 4,388 15,765
Supplemental schedule of non-cash activity:    
Transfer of property under development to rental property 55,538 69,770
Non-cash Conversion of Mortgage Note Receivable to Real Estate 72,800 0
Issuance of nonvested shares and restricted share units at fair value, including nonvested shares issued for payment of bonuses 28,302 28,214
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 37,820 0
Operating Lease, Cost 37,820 0
Supplemental disclosure of cash flow information:    
Interest Paid, Excluding Capitalized Interest, Operating Activity 68,354 68,015
Cash paid during the period for income taxes 3,091 1,987
Interest cost capitalized 588 2,396
Change in accrued capital expenditures $ (5,260) $ (4,791)